Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial

发表于前天 18:29

期刊：American Journal of Respiratory and Critical Care Medicine

文献作者：Roham T. Zamanian; David Badesch; Lorinda Chung; Robyn T. Domsic; Thomas Medsger; Ashley Pinckney; Lynette Keyes-Elstein; Carla D’Aveta; Meagan Spychala; R. James White; Paul M. Hassoun; Fernando Torres; Andrew J. Sweatt; Jerry A. Molitor; Dinesh Khanna; Holden Maecker; Beverly Welch; Ellen Goldmuntz; Mark R. Nicolls

出版日期：2021-7-15

DOI号：10.1164/rccm.202009-3481oc

下载链接：https://academic.oup.com/ajrccm/ ... jrccm_204_2_209.pdf

文献链接：https://doi.org/10.1164/rccm.202009-3481oc

当前文献来源于 Oxford University Press (OUP)。

备注信息：

[ATS] Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ATS] Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial 一键复制